申请人:VERSEON CORPORATION
公开号:US10189810B2
公开(公告)日:2019-01-29
There are provided inter alia pyrazolyl-substituted pyridone compounds, which exhibit biological activity, e.g., inhibitory action, against serine proteases, including thrombin and various kallikreins. There are additionally provided pharmaceutical compositions. There are additionally provided methods of treating and preventing certain diseases or disorders, which disease or disorder is amenable to treatment or prevention by the inhibition of serine proteases, including thrombin and various kallikreins.
除其他外,还提供了吡唑基取代的吡啶酮化合物,这些化合物对丝氨酸蛋白酶(包括凝血酶和各种卡里克蛋白)具有生物活性,例如抑制作用。另外还提供了药物组合物。另外还提供了治疗和预防某些疾病或失调的方法,这些疾病或失调可通过抑制丝氨酸蛋白酶(包括凝血酶和各种卡里克蛋白)来治疗或预防。